Y-mAbs announces FDA clearance of IND for its Lutetium-177 labelled omburtamab antibody

This article was originally published here

Medulloblastomas are invasive, rapidly growing tumors that, unlike most brain tumors, spread through the cerebrospinal fluid and frequently metastasize to different locations along the surface of the brain

The post Y-mAbs announces FDA clearance of IND for its Lutetium-177 labelled omburtamab antibody appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply